Samyang Biopharm Corporation (KRX:0120G0)
South Korea
· Delayed Price · Currency is KRW 84,600
-8,100 (-8.74%)
Last updated: Mar 9, 2026, 2:29 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 632.05 billion as of March 9, 2026.
Market Cap
632.05B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
84,600.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 632.05B, an increase of 181.46%. That is a compound annual growth rate of 3,549.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 632.05B | 61.90% |
| Dec 30, 2025 | 390.38B | 73.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 569.59B |
| HEM Pharma | 535.01B |
| Myung In Pharmaceutical LTD. | 905.20B |
| CellBion | 359.28B |
| G2GBIO | 1,697.89B |
| DAE HWA Pharmaceutical | 250.31B |
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |